Minimal residual disease negativity predicts time to next treatment in multiple myeloma

by Elana GotkineFor patients with multiple myeloma (MM), minimal residual disease (MRD) negativity determined using next-generation sequencing (NGS) is predictive of longer time to next treatment (TTN

Updated on: January 22,2024

Minimal residual disease negativity predicts time to next treatment in multiple myeloma

by Elana GotkineFor patients with multiple myeloma (MM), minimal residual disease (MRD) negativity determined using next-generation sequencing (NGS) is predictive of longer time to next treatment (TTN

Updated on:January 22,2024

Brain boost: Can a coach help elders at risk for Alzheimer's?

by University of California, San FranciscoCredit: Unsplash/CC0 Public DomainAs more medications move towards federal approval for Alzheimer's disease, a new study led by researchers at UC San

Updated on: April 18,2024

Brain boost: Can a coach help elders at risk for Alzheimer's?

by University of California, San FranciscoCredit: Unsplash/CC0 Public DomainAs more medications move towards federal approval for Alzheimer's disease, a new study led by researchers at UC San

Updated on:April 18,2024

The right moves: How studying cell movement during embryonic development may offer new insights into cancer metastasis

by Ian Demsky,Memorial Sloan Kettering Cancer CenterUnder the microscope, MSK scientists studied how cells in a mouse embryo (green) move out and break away from their original tissue by contrac

Updated on: February 23,2024

The right moves: How studying cell movement during embryonic development may offer new insights into cancer metastasis

by Ian Demsky,Memorial Sloan Kettering Cancer CenterUnder the microscope, MSK scientists studied how cells in a mouse embryo (green) move out and break away from their original tissue by contrac

Updated on:February 23,2024

AI-driven attention mechanisms aid in streamlining cancer pathology reporting

by Mark Alewine,Oak Ridge National LaboratoryCredit: Pixabay/CC0 Public DomainArtificial Intelligence researchers have taken a major step forward in using AI in the fight against cancer.In partn

Updated on: March 30,2024

AI-driven attention mechanisms aid in streamlining cancer pathology reporting

by Mark Alewine,Oak Ridge National LaboratoryCredit: Pixabay/CC0 Public DomainArtificial Intelligence researchers have taken a major step forward in using AI in the fight against cancer.In partn

Updated on:March 30,2024

Study finds racial disparities in culturally competent cancer care

by Dana-Farber Cancer InstituteBrandon A. Mahal, MD of Dana-Farber Cancer Institute, co-senior author of the study published inJAMA Oncology. Credit: Dana-Farber Cancer InstituteMany non-wh

Updated on: July 04,2024

Study finds racial disparities in culturally competent cancer care

by Dana-Farber Cancer InstituteBrandon A. Mahal, MD of Dana-Farber Cancer Institute, co-senior author of the study published inJAMA Oncology. Credit: Dana-Farber Cancer InstituteMany non-wh

Updated on:July 04,2024

The virtual cancer patient

by Technische Universitat DarmstadtIn the laboratory: Professor Heinz Koeppl (left) and his research associate Jascha Diemer. Credit: Katrin BinnerNo two cancers are the same. Each type of leukae

Updated on: March 01,2024

The virtual cancer patient

by Technische Universitat DarmstadtIn the laboratory: Professor Heinz Koeppl (left) and his research associate Jascha Diemer. Credit: Katrin BinnerNo two cancers are the same. Each type of leukae

Updated on:March 01,2024

Triplet therapy including belamaf prolongs survival in multiple myeloma

by Elana GotkineFor patients with relapsed or refractory multiple myeloma (RRMM), triplet therapy of belantamab mafodotin (belamaf) plus bortezomib and dexamethasone (BVd) improves outcomes, with an a

Updated on: March 24,2024

Triplet therapy including belamaf prolongs survival in multiple myeloma

by Elana GotkineFor patients with relapsed or refractory multiple myeloma (RRMM), triplet therapy of belantamab mafodotin (belamaf) plus bortezomib and dexamethasone (BVd) improves outcomes, with an a

Updated on:March 24,2024

New study shows patient/clinician identity differences are a factor in cancer care

byJohns Hopkins University School of MedicineCredit: Unsplash/CC0 Public DomainA new study by researchers at the Johns Hopkins Kimmel Cancer Center in collaboration with Dell Medical School, Uni

Updated on: January 12,2024

New study shows patient/clinician identity differences are a factor in cancer care

byJohns Hopkins University School of MedicineCredit: Unsplash/CC0 Public DomainA new study by researchers at the Johns Hopkins Kimmel Cancer Center in collaboration with Dell Medical School, Uni

Updated on:January 12,2024

Thousands of cervical screening samples are waiting to be tested, says report

by Cancer Research UKCredit: CC0 Public DomainMore than 150,000 cervical screening samples were waiting to be tested by NHS laboratories across England last year, according to a report.A study fr

Updated on: March 08,2024

Thousands of cervical screening samples are waiting to be tested, says report

by Cancer Research UKCredit: CC0 Public DomainMore than 150,000 cervical screening samples were waiting to be tested by NHS laboratories across England last year, according to a report.A study fr

Updated on:March 08,2024

Study uncovers potential therapeutic approach for advanced prostate cancer

by Melissa Rohman,Northwestern UniversityPALI1 bridges the interaction between PRC2 (SUZ12/EZH2/EED) and G9A to catalyze dual H3K9 and H3K27 methylation, which leads to strong repression of GPS

Updated on: February 01,2024

Study uncovers potential therapeutic approach for advanced prostate cancer

by Melissa Rohman,Northwestern UniversityPALI1 bridges the interaction between PRC2 (SUZ12/EZH2/EED) and G9A to catalyze dual H3K9 and H3K27 methylation, which leads to strong repression of GPS

Updated on:February 01,2024

Study: Vaccine helps drug keep melanoma patients cancer-free

by Angelica PeeblesCredit: Unsplash/CC0 Public DomainAdding a personalized cancer vaccine to the blockbuster drug Keytruda kept more melanoma patients in remission than the immune therapy alone, co-de

Updated on: February 03,2024

Study: Vaccine helps drug keep melanoma patients cancer-free

by Angelica PeeblesCredit: Unsplash/CC0 Public DomainAdding a personalized cancer vaccine to the blockbuster drug Keytruda kept more melanoma patients in remission than the immune therapy alone, co-de

Updated on:February 03,2024

Research reveals potential targets for therapeutic development for glioblastoma

by Amy Richardson,University of Alabama at BirminghamGraphical abstract. Credit:JCI Insight(2022). DOI: 10.1172/jci.insight.148717The University of Alabama at Birmingham Marnix E. He

Updated on: February 03,2024

Research reveals potential targets for therapeutic development for glioblastoma

by Amy Richardson,University of Alabama at BirminghamGraphical abstract. Credit:JCI Insight(2022). DOI: 10.1172/jci.insight.148717The University of Alabama at Birmingham Marnix E. He

Updated on:February 03,2024